Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatic Encephalopathy

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

Encephalitis ll: Pathophysiology

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pediatric hepatic pseudoaneurysm formation following blunt and penetrating abdominal trauma: a 5-year retrospective analysis.

Journal of trauma and injury·2026

Same author

Generative artificial intelligence adoption and use in teaching and training healthcare professionals in higher education in the United States: a cross-sectional study.

BMC medical education·2026

Same author

Healthcare Providers' Perspectives on Generative Artificial Intelligence (GenAI) Adoption, Adaptation, Assimilation, and Use in the United States.

Healthcare (Basel, Switzerland)·2026

Same author

Disordered Bile Acid Metabolism in Alcohol-Related Hepatitis.

Alimentary pharmacology & therapeutics·2026

Same author

Transforming Public Health Practice with Artificial Intelligence: A Framework-Driven Approach.

Healthcare (Basel, Switzerland)·2026

Same author

ETHICS of AI Adoption and Deployment in Health Care: Progress, Challenges, and Next Steps.

JMIR AI·2025

Search research articles

Related Experiment Video

Updated: May 25, 2026

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with ¹⁸F-FDG

Published on: December 28, 2014

Brain imaging and hepatic encephalopathy.

Mark J W McPhail¹, Neeral R Patel, Simon D Taylor-Robinson

¹Liver and Antiviral Center, Department of Medicine, St Mary's Hospital Campus, Imperial College London, 10th Floor QEQM Wing, South Wharf Street, London W2 1NY, UK. mark.mcphail@imperial.ac.uk

Clinics in Liver Disease

|February 11, 2012

Summary

Quantitative MRI shows promise as an objective diagnostic tool for hepatic encephalopathy, offering detailed insights into brain changes. This technique could become a standard clinical test, improving diagnosis beyond traditional methods.

Related Experiment Videos

Last Updated: May 25, 2026

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with 18F-FDG

Non-invasive Imaging and Analysis of Cerebral Ischemia in Living Rats Using Positron Emission Tomography with ¹⁸F-FDG

Published on: December 28, 2014

Area of Science:

Neurology
Radiology
Medical Imaging

Background:

Hepatic encephalopathy (HE) neuropathology requires advanced imaging, but clinical applicability is limited.
Current clinical imaging (CT, MRI) aids differential diagnosis but lacks objective HE-specific markers.
An objective imaging biomarker for HE diagnosis is needed to complement or replace psychometric testing.

Purpose of the Study:

To review the clinical utility of magnetic resonance (MR) and nuclear medicine imaging in hepatic encephalopathy.
To discuss recent research findings on advanced imaging techniques for HE.
To evaluate quantitative MRI as a potential objective diagnostic standard for HE.

Main Methods:

Review of current literature on MR and nuclear medicine techniques in hepatic encephalopathy.
Analysis of the diagnostic capabilities of computed tomography (CT) and magnetic resonance imaging (MRI).
Assessment of quantitative MRI as a potential objective diagnostic biomarker.

Main Results:

Standard MRI sequences can identify diagnostic features of HE and rule out other conditions.
Quantitative MRI techniques show potential for objective HE assessment.
Nuclear medicine and advanced MR techniques offer detailed neuropathological insights but require further clinical validation.

Conclusions:

Quantitative MRI is the most promising candidate for an objective, clinically applicable diagnostic test for hepatic encephalopathy.
Further research and standardization are needed to establish quantitative MRI as a clinical standard.
Advanced imaging techniques are crucial for understanding and diagnosing HE, with a move towards objective biomarkers.